Cargando…
Arginine methylation: the promise of a ‘silver bullet’ for brain tumours?
Despite intense research efforts, our pharmaceutical repertoire against high-grade brain tumours has not been able to increase patient survival for a decade and life expectancy remains at less than 16 months after diagnosis, on average. Inhibitors of protein arginine methyltransferases (PRMTs) have...
Autores principales: | Samuel, Sabrina F., Barry, Antonia, Greenman, John, Beltran-Alvarez, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107164/ https://www.ncbi.nlm.nih.gov/pubmed/33404912 http://dx.doi.org/10.1007/s00726-020-02937-x |
Ejemplares similares
-
Inhibiting Arginine Methylation as a Tool to Investigate Cross-Talk with Methylation and Acetylation Post-Translational Modifications in a Glioblastoma Cell Line
por: Samuel, Sabrina Francesca, et al.
Publicado: (2018) -
Is Silver the Ultimate Antimicrobial Bullet?
por: Turner, Raymond J
Publicado: (2018) -
Hydroxylamine Analogue of Agmatine: Magic Bullet for Arginine Decarboxylase
por: Hyvönen, Mervi T., et al.
Publicado: (2020) -
Heparin: The Silver Bullet of Aneurysmal Subarachnoid Hemorrhage?
por: Khattar, Nicolas K., et al.
Publicado: (2018) -
How to run successful projects II: the silver bullet
por: O'Connell, Fergus
Publicado: (1994)